BioNTech SE (ETR:22UA)
91.35
-4.60 (-4.79%)
At close: Aug 1, 2025, 5:30 PM CET
BioNTech SE Revenue
BioNTech SE had revenue of 182.80M EUR in the quarter ending March 31, 2025, a decrease of -2.56%. This brings the company's revenue in the last twelve months to 2.75B, up 0.61% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.
Revenue (ttm)
2.75B
Revenue Growth
+0.61%
P/S Ratio
8.34
Revenue / Employee
405.54K
Employees
6,772
Market Cap
22.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
BioNTech SE News
- 2 days ago - Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent - Fast Company
- 2 days ago - BioNTech Q2 2025 Earnings Preview - Seeking Alpha
- 2 days ago - A Look Ahead: BioNTech's Earnings Forecast - Benzinga
- 2 days ago - Pfizer/BioNTech lose appeal to reverse Moderna’s COVID vaccine patent win in U.K. - Seeking Alpha
- 2 days ago - UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech - Wallstreet:Online
- 2 days ago - Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win - Reuters
- 3 days ago - Pandemic darlings Moderna, BioNTech are now on two different paths - CNBC
- 9 days ago - Pfizer, BioNTech win EU backing for updated COVID shot - Seeking Alpha